Thromb Haemost 1982; 48(02): 120-124
DOI: 10.1055/s-0038-1657238
Original Article
Schattauer GmbH Stuttgart

Reversible Inhibition of the In Vitro Coagulation of Human Plasma by Lectins

J-M Freyssinet
The DRF-Laboratoire d'Hématologie, Unité 217 INSERM, Centre d'Etudes Nucléaires, Grenoble, France
,
D Thevenon
The DRF-Laboratoire d'Hématologie, Unité 217 INSERM, Centre d'Etudes Nucléaires, Grenoble, France
,
A Souque
The DRF-Laboratoire d'Hématologie, Unité 217 INSERM, Centre d'Etudes Nucléaires, Grenoble, France
,
M Suscillon
The DRF-Laboratoire d'Hématologie, Unité 217 INSERM, Centre d'Etudes Nucléaires, Grenoble, France
› Author Affiliations
Further Information

Publication History

Received 14 April 1982

Accepted 25 June 1982

Publication Date:
13 July 2018 (online)

Summary

Wheat germ agglutinin (WGA) and concanavalin A (Con-A) (also red kidney bean agglutinin, PHA) have been found to be inhibitors of plasma clotting in vitro. At 40 µg/ml and 250 µg/ml (4.4 µM and 10 µM in carbohydrate binding sites, final concentrations) respectively, WGA and Con-A are able to double the activated partial thromboplastin time of normal human control plasma. Their inhibitory effect is due to their capacity to interact with the carbohydrate portion of blood clotting factors. It is totally abolished in the presence of specific saccharides for WGA or Con-A and is attenuated in the presence of 4% (v/v, final concentration) of human erythrocytes. The action of WGA is mediated by its ability to interact with N-acetylneuraminic acid. When purified phospholipid vesicles plus kaolin are used as an activator instead of cephalidin, this effect persists to the same extent. These two lectins also prolong the plasma clotting time using Russell's viper venom plus purified phospholipid vesicles as an activator. Quick's time was also prolonged by WGA and Con-A but to a lesser extent in this case. WGA can interact directly with some purified blood clotting factors (IX, X and II) in a classical lectin-glycoprotein precipitin reaction. When assessed at individual factors level in whole plasma using clotting assays, direct inhibitions by WGA are only apparent.

 
  • References

  • 1 Davie EW, Hanahan DJ. Blood coagulation proteins, in The Plasma Proteins. Putnam FW. ed. Academic Press; New York: 1977. 3: 421-544
  • 2 Jackson CM, Nemerson Y. Blood coagulation. Annu Rev Biochem 1980; 49: 765-811
  • 3 Montreuil J. Primary structure of glycoprotein glycans. Adv Carbohydr Chem Biochem 1980; 37: 157-223
  • 4 Sharon N, Lis H. Glycoproteins: research booming on long-ignored ubiquitous compounds. Mol Cell Biochem 1982; 42: 167-187
  • 5 Goldstein IJ, Hayes CE. The lectins: Carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem 1978; 35: 125-340
  • 6 Monsigny M, Kieda C, Roche A-C. Membrane lectins. Biol. Cellulaire 1979; 35: 289-300
  • 7 Legaz ME, Davie EW. Bovine factor VIII (Antihemophilic factor). Methods Enzymol 1976; 45: 83-89
  • 8 Fujikawa K, Davie EW. Bovine factor IX (Christmas factor). Methods Enzymol 1976; 45: 74-83
  • 9 Fujikawa K, Davie EW. Bovine factor X (Stuart factor). Methods Enzymol 1976; 45: 89-95
  • 10 Caen J, Larrieu MJ, Samama M. L’hémostase. L’Expansion Scientifique. Paris: 1968
  • 11 Huang C, Thomson TE. Preparation of homogeneous, single-walled phosphatidylcholine vesicles. Methods Enzymol 1974; 22: 485-489
  • 12 Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466-468
  • 13 Nelsestuen GL, Lim TK. Equilibria involved in prothrombin and blood clotting factor X - membrane binding. Biochemistry 1977; 16: 4164-4171
  • 14 Zwall RFA, Comfurius P, Van Deenen LLM. Membrane asymmetry and blood coagulation. Nature 1977; 268: 358-360
  • 15 Aurell L, Friberger P, Karlson G, Claeson G. A new sensitive and highly specific chromogenic peptide substrate for factor Xa. Thromb Res 1977; 11: 595-609
  • 16 Pepper DS, Prowse C. Chromatography of human prothrombin complex on dextran sulphate. Thromb Res 1977; 11: 687-692
  • 17 Prowse CV, Mattock P, Esnouf MP, Russel AM. A variant of prothrombin induced in cattle by prolonged administration of warfarin. Biochim Biophys Acta 1976; 434: 265-279
  • 18 Monsigny M, Sene C, Obrenovitch A, Roche A-C, Delmotte F, Boschetti E. Properties of succinylated wheat-germ agglutinin. Eur J Biochem 1979; 98: 39-45
  • 19 Lajmanovich A, Hudry-Clergeon G, Freyssinet J-M, Marguerie G. Human Factor VIII procoagulant activity and phospholipid interaction. Biochim Biophys Acta 1981; 678: 132-136
  • 20 Freyssinet J-M. Wheat germ lectin, a tool to investigate metal ioninduced structural changes of bovine blood coagulation factor X1 . FEBS Lett 1981; 124: 48-52
  • 21 Nemerson Y, Furie B. Zymogens and cofactors of blood coagulation. CRC Crit Rev Biochem 1980; 9: 45-85
  • 22 Mizuochi T, Yamashita K, Fujikawa K, Kisiel W, Kobata A. The carbohydrate of bovine prothrombin. J Biol Chem 1979; 254: 6419-6425
  • 23 Mizuochi T, Yamashita K, Fujikawa K, Titani K, Kobata A. The structures of the carbohydrate moieties of bovine blood coagulation factor X. J Biol Chem 1980; 255: 3526-3531
  • 24 Franzen LE, Svensson S, Larm O. Structural studies of the carbohydrate portion of human antithrombin III. J Biol Chem 1980; 255: 5090-5093
  • 25 Roche A-C, Schauer R, Monsigny M. Protein sugar interactions. Purification by affinity chromatography of limulin, an N-acylneuraminidyl-binding protein. FEBS Lett 1975; 57: 245-249